Ota S, Inaba H, Yoshida H
Department of Thoracic Surgery, Shizuoka General Hospital, Shizuoka, Japan.
Kyobu Geka. 2001 Dec;54(13):1073-8; discussion 1078-81.
Between January 1989 and December 1998, 134 cases of squamous cell carcinoma and 244 cases of adenocarcinoma underwent surgical resection of the lung with systematic lymph node dissection in our hospital. The cN diagnosis by CT scan and pN diagnosis were compared. In squamous cell carcinoma pN 2-3 cases were only one patient (2%) out of 60 patients with cN 0, 5 patients (18%) out of 28 patients with cN 1, and 21 patients (46%) out of 46 patients with cN 2-3. On the other hand in adenocarcinoma pN 2-3 cases were 27 patients (14%) out of 193 patients with cN 0, 3 patients (25%) out of 12 patients with cN 1, and 24 patients (62%) out of 39 patients with cN 2-3. The pathways of the lymphatic metastases to the mediastinal nodes were analized in 27 patients with squamous cell carcinoma and 54 patients with adenocarcinoma undergoing systematic lymph node dissection. All patients had histologically proven mediastinal metastasis. Histologically there was no difference in pathways of the lymphatic metastases to the mediastinal nodes. 1. The dominant lymphatic drainage from the right upper lobe flowed into the superior mediastinal nodes. The direct metastatic passages to the superior mediastinal nodes were observed (47%). Subcarinal and inferior mediastinal node involvement was rare (3%). 2. The dominant lymphatic drainage from the middle and the lower lobe flowed into the subcarinal nodes (85%). The involvement of the superior mediastinal nodes occurred in 53% of subcarinal node positive patients on the right side. 3. The dominant lymphatic drainage from the left upper lobe flowed into the subaortic or paraaortic nodes (69%). Subcarinal and inferior mediastinal node involvement was rare (6%). We conclude that subcarinal and inferior mediastinal lymph node dissection is not necessary for upper lobe lung cancers, and that superior mediastinal lymph node dissection can be omitted in middle and lower lobe lung cancers without hilar and subcarinal lymph node involvement, especially in the cases of cN 0.
1989年1月至1998年12月期间,我院对134例鳞状细胞癌和244例腺癌患者进行了肺手术切除并系统性淋巴结清扫。比较了CT扫描的cN诊断和pN诊断。在鳞状细胞癌中,cN 0的60例患者中pN 2 - 3期仅1例(2%),cN 1的28例患者中有5例(18%),cN 2 - 3的46例患者中有21例(46%)。另一方面,在腺癌中,cN 0的193例患者中pN 2 - 3期有27例(14%),cN 1的12例患者中有3例(25%),cN 2 - 3的39例患者中有24例(62%)。对27例接受系统性淋巴结清扫的鳞状细胞癌患者和54例腺癌患者的纵隔淋巴结淋巴转移途径进行了分析。所有患者均经组织学证实有纵隔转移。组织学上,纵隔淋巴结的淋巴转移途径无差异。1. 右上叶的主要淋巴引流流入上纵隔淋巴结。观察到直接转移至纵隔淋巴结的途径(47%)。隆突下和下纵隔淋巴结受累罕见(3%)。2. 中叶和下叶的主要淋巴引流流入隆突下淋巴结(85%)。右侧隆突下淋巴结阳性患者中53%出现上纵隔淋巴结受累。3. 左上叶的主要淋巴引流流入主动脉下或主动脉旁淋巴结(69%)。隆突下和下纵隔淋巴结受累罕见(6%)。我们得出结论,对于上叶肺癌,隆突下和下纵隔淋巴结清扫不必要,对于中叶和下叶肺癌,若无肺门和隆突下淋巴结受累,尤其是cN 0的病例,可以省略上纵隔淋巴结清扫。